SCHEMBL30692989

SCHEMBL30692989

O=C(O)CC1CCN(CC2CCN(c3ccc4c(c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 17/20 0.65
▸ AR P10275 3/20 0.58
▸ BTK Q06187 2/20 0.51
▸ DDB1 Q16531 8/20 0.49
▸ CDK9 P50750 1/20 0.48
▸ ITK Q08881 1/20 0.48
▸ IRAK1 P51617 1/20 0.47
▸ IRAK4 Q9NWZ3 1/20 0.47
▸ IRAK3 Q9Y616 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ CHRM2 P08172 1/20 0.47
▸ OPRM1 P35372 1/20 0.47
▸ IKZF3 Q9UKT9 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ ESR1 P03372 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26929077 1.00 CRBN (0.65) CRBNARBTKDDB1CDK9
SCHEMBL26928997 0.95 CRBN (0.60) CRBNARBTKDDB1ALDH1A1
SCHEMBL30692979 0.95 CRBN (0.60) CRBNARBTKDDB1ALDH1A1
SCHEMBL23301420 0.94 CRBN (0.72) CRBNARDDB1ALDH1A1CHRM2
SCHEMBL27176460 0.91 CRBN (0.65) CRBNARBTKDDB1CDK9
SCHEMBL24206867 0.91 CRBN (0.65) CRBNARBTKDDB1CDK9
SCHEMBL29681788 0.91 CRBN (0.65) CRBNARBTKDDB1CDK9
SCHEMBL26969669 0.90 CRBN (0.69) CRBNARBTKDDB1CDK9
SCHEMBL31447732 0.89 CRBN (0.80) CRBNARBTKDDB1CDK9
SCHEMBL23860209 0.88 CRBN (0.66) CRBNARBTKDDB1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025228947-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF INDUCING DEGRADATION OF POLO-LIKE KINASE1 CROSSFIRE ONCOLOGY B.V. (NL) 2025-11-06 — — WO disclosed
WO-2023239629-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT DEGRADE CDK2 Plexium, Inc. (US) 2023-12-14 — — WO disclosed
Send feedback